Why This Matters
Paramount Skydance’s push to win over the exhibition community has become a revealing test of where power sits in Hollywood’s still-fragile theatrical ecosystem. The company’s campaign to build support for a proposed combination with Warner Bros. Discovery is not just about corporate scale or Wall Street math. It is also about convincing theater owners that another round of consolidation will put more movies, not fewer, on their screens.
That message has landed with some of the industry’s biggest exhibitors. AMC, Regal and Vue have publicly signaled support for David Ellison and the broader merger effort, lending the campaign a measure of credibility at a moment when studios and theater chains remain mutually dependent but frequently wary of one another. For exhibitors, the argument is straightforward: if a merged entity pledges to increase theatrical output, protect wide releases and invest in films built for cinemas, that could help stabilize a business still working its way back from the pandemic, labor strikes and an uneven release calendar.
But the enthusiasm is far from universal. Across the theatrical world, many executives remain cautious about endorsing a deal that could reshape the studio landscape yet again. Their concern is not simply whether Paramount Skydance can say the right things in public. It is whether any merged company, once under pressure to cut costs and satisfy investors, will keep theatrical promises when streaming, debt reduction and corporate integration become the daily priorities.
The skepticism is heightened by the legal and political scrutiny surrounding the deal. With a group of state attorneys general challenging the merger, public support from high-profile entertainment executives has become part of a broader persuasion campaign. Statements from exhibitors and other industry figures can help create the impression that the deal serves the marketplace rather than threatens it. Still, in an industry accustomed to splashy assurances that later collide with balance sheets, many theater operators are reading the fine print.
Industry Context
Theater owners have good reason to view studio consolidation with mixed feelings. Over the past decade, mergers and corporate restructurings have altered release strategies, reduced the number of major suppliers and intensified the battle between theatrical distribution and streaming platforms. Every time the studio field narrows, exhibitors worry about fewer films, shorter windows and more leverage concentrated in the hands of fewer companies.
Paramount and Warner Bros. are especially important to cinemas because both carry deep theatrical identities. Paramount has long been associated with event franchises and commercially minded filmmaking, while Warner Bros. remains one of the few studios with a consistent record of backing large-scale theatrical releases across genres. A union involving those assets could, in theory, create a more muscular supplier of films at a time when theaters need volume, variety and reliable tentpoles.
That is the optimistic case being presented to exhibitors. Ellison, who has sought to position himself as a believer in the big screen, has emphasized theatrical output as a core part of the pitch. A written pledge to increase the number of films made for cinemas is designed to address the industry’s central anxiety: that consolidation often begins with promises of growth and ends with fewer greenlights.
For large chains, public support may reflect both hope and pragmatism. AMC, Regal and Vue operate at a scale that depends on steady studio pipelines. They have an incentive to encourage any buyer or merger partner that says it will prioritize theaters. They also understand that building relationships with the next generation of studio leadership can matter when release calendars, marketing commitments and premium-format strategies are being negotiated.
Smaller and regional exhibitors, however, may be more reluctant to join the chorus. Many have lived through years of inconsistent product flow, films bypassing theaters and studios experimenting with windows in ways that disadvantaged independent operators. For them, a promise from a merged studio is only as strong as the release schedule that follows. They want to know whether mid-budget films will return, whether family titles will be reliably theatrical and whether non-franchise releases will receive genuine marketing support rather than token engagements.
The political backdrop also complicates matters. Antitrust scrutiny has become more aggressive in several sectors, and entertainment mergers are no longer judged only by whether consumers might pay higher prices. Regulators are increasingly attentive to labor impact, supplier diversity, regional markets and the competitive consequences of combining major content libraries. A handful of supportive quotes from theater executives may help Paramount Skydance argue that the deal benefits cinemas, but it is unlikely to settle the larger regulatory debate.
The broader question facing Hollywood is whether scale is still the answer. Studios argue that global competition from tech giants requires bigger libraries, stronger balance sheets and more efficient operations. Theater owners counter that scale means little if it produces fewer films and less risk-taking. The exhibition business does not survive on corporate synergy; it survives on weekly reasons for audiences to leave home.
What Happens Next?
The next phase will likely be fought on multiple fronts: in court, in the press and in private conversations with key industry constituencies. Paramount Skydance can be expected to continue highlighting supportive voices from exhibition and creative circles, particularly those who frame the merger as a pathway to a stronger theatrical slate. The company’s challenge will be to convert broad statements of confidence into specific assurances that exhibitors believe can survive post-merger cost pressures.
Theater executives who remain undecided will be watching for details. How many theatrical releases would the combined company commit to annually? What kind of films would those be? Would the studio maintain separate labels and development pipelines, or would overlap lead to reductions? How would premium formats, international distribution and release windows be handled? Those answers may matter more than any public endorsement.
Regulators, meanwhile, will look past the industry applause to assess whether the merger could reduce competition in production, distribution or licensing. Support from AMC, Regal and Vue may help demonstrate that some major exhibitors see upside, but opponents will likely argue that theatrical promises are difficult to enforce and may not offset broader concerns about market concentration.
For now, the exhibition community is divided between those willing to take Ellison’s theatrical pitch at face value and those waiting for proof that consolidation will not mean contraction. In a business still rebuilding audience habits, that divide is significant. Theaters need allies with deep pockets and a belief in the communal moviegoing experience. They also need more than optimism. They need movies on the calendar, marketing behind them and a studio partner whose commitment to cinemas lasts beyond the merger campaign.